Kanger’s executive director Steven Kuah Choon Ching (pic) said in a press release that the company is pleased to be in this MOU to facilitate the distribution of Sinopharm’s Covid-19 vaccines in Malaysia.
PETALING JAYA: ACE Market-listed Kanger International Bhd
has entered into a memorandum of understanding (MoU) with Zuellig Pharma Sdn Bhd for Covid-19 vaccine distribution in Malaysia.
Zuellig Pharma is one of the license holders authorised by the Malaysian Government to handle the distribution of vaccines.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
